As the main effect of incretin-based therapies regarding the weight loss lies on hypothalamus, there are concerns regarding the efficacity of these drugs in the case that regions of the hypothalamus are affected by a surgery in the area or if intracellular signaling in hypothalamus is affected by mutations in cases of monogenic obesity. Here, GCG is linked to Obesity.